P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors
Poseida Therapeutics, Inc.
Poseida Therapeutics, Inc.
SystImmune Inc.
Novartis
Incyte Corporation
Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd
Xencor, Inc.